Pressure BioSciences, Inc. (Nasdaq: PBIO) reported Q1 loss of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $181 thousand versus the consensus estimate of $280 thousand.

Earnings